Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, an SGLT2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults.
British journal of clinical pharmacology（2022）
摘要
The results suggest that the DWP16001 could be added to metformin and gemigliptin combination therapy without dose adjustment.
更多查看译文
关键词
Diabetes,Drug interactions,Pharmacodynamics,Pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要